Recently Completed Studies

1. Amgen, Inc. 

A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

2. Eli Lilly & Co. J2A-MC-GZGI

A Phase 2 Study of Once-Daily LY3502970 Compared with Placebo in Participants Who Have Obesity or Are Overweight with Weight-Related Comorbidities

3. Eli Lilly & Co. I8H-MC-BDCM

A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants with Type 2 Diabetes Mellitus Previously Treated with Basal Insulin

4. Lexicon LX9211.1-201-DPN

A Phase 2, Randomized, Double-blind, Placebo controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of LX9211 in the Treatment of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1)

5. Lexicon LX9211.1-202-PHN

A Phase 2, Double-blind, Randomized, Placebo controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Postherpetic Neuralgia (RELIEF-PHN1)